|
Melanoma prevention by MC1R selective small peptide analogs of alpha MSH
|
1R21CA191761-01A1
|
$221,595
|
$221,595
|
ABDEL-MALEK, ZALFA
|
UNIVERSITY OF CINCINNATI
|
|
Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts
|
1R03CA186218-01A1
|
$81,186
|
$81,186
|
ABRAMS, JULIAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Colon Cancer Chemoprevention by Flavonoid Silibinin
|
5R01CA112304-10
|
$286,515
|
$286,515
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-02
|
$387,195
|
$387,195
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$871,993
|
$174,399
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Chemoprevention of Skin Cancer Program Project
|
3P01CA027502-32S1
|
$11,328
|
$11,328
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Chemoprevention of Skin Cancer Program Project
|
5P01CA027502-32
|
$1,312,638
|
$1,312,638
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Targeting defective DNA repair for the prevention of BRCA1-associated cancers
|
1K22CA181550-01
|
$162,000
|
$162,000
|
ALLI, ELIZABETH
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 - 07130
|
$1,717,771
|
$343,554
|
Alter, Blanche
|
DCEG (NCI)
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-02
|
$544,710
|
$544,710
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
1R01CA196854-01
|
$725,110
|
$725,110
|
ARMENIAN, SARO
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer
|
5R01CA138998-05
|
$303,988
|
$303,988
|
ATHAR, MOHAMMAD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$374
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Colorectal Chemoprevention with Calcium and Vitamin D
|
5R01CA098286-13
|
$2,234,370
|
$2,234,370
|
BARON, JOHN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Aspirin Metabolomics in Colorectal Cancer Chemoprevention
|
1R01CA188038-01A1
|
$377,365
|
$377,365
|
BARRY, ELIZABETH
|
DARTMOUTH COLLEGE
|
|
Dopamine as a therapeutic agent in stomach cancer
|
5R01CA169158-03
|
$319,550
|
$159,775
|
BASU, SUJIT
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
2P30CA042014-26
|
$1,639,000
|
$49,170
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S1
|
$31,248
|
$937
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S2
|
$50,000
|
$1,500
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S3
|
$249,799
|
$7,494
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S4
|
$123,315
|
$3,699
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S5
|
$150,000
|
$4,500
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S6
|
$178,513
|
$5,355
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Histone Methyltransferases as a Target for Lung Cancer Prevention
|
5R01CA183296-02
|
$581,472
|
$581,472
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
Ovarian Cancer Chemoprevention
|
1R01CA196200-01A1
|
$611,847
|
$611,847
|
BENBROOK, DORIS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Cancer Center Support Grant
|
3P30CA006516-50S1
|
$122,500
|
$4,900
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S2
|
$50,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S3
|
$125,000
|
$5,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S4
|
$200,000
|
$8,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S5
|
$62,500
|
$2,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-50
|
$11,162,542
|
$446,502
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-33S1
|
$62,500
|
$3,750
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-33
|
$2,529,146
|
$151,749
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-29S2
|
$334,740
|
$26,779
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Research Training Program in Surgical Oncology
|
5T32CA091078-14
|
$359,864
|
$53,980
|
BLAND, KIRBY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
GUCY2C hormone suppression links obesity with colorectal cancer
|
5F30CA180500-03
|
$43,798
|
$14,453
|
BLOMAIN, ERIK
|
THOMAS JEFFERSON UNIVERSITY
|
|
Colon Cancer Chemoprevention with Phosphodiesterase-5 Inhibitors
|
5R01CA172627-03
|
$311,250
|
$311,250
|
BROWNING, DARREN
|
GEORGIA REGENTS UNIVERSITY
|
|
SPORE in Lung Cancer
|
5P50CA058187-20
|
$2,185,000
|
$1,092,500
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Chemoprevention through Chromatin modulation in Barrett's esophagus
|
5R03CA189404-02
|
$79,500
|
$79,500
|
BUTTAR, NAVTEJ
|
MAYO CLINIC ROCHESTER
|
|
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention
|
1R01CA185301-01A1
|
$352,275
|
$352,275
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-39S1
|
$62,500
|
$2,500
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-39S2
|
$60,126
|
$2,405
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-39S3
|
$31,250
|
$1,250
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-39
|
$4,582,303
|
$183,292
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Oncology Training Grant
|
5T32CA009338-37
|
$501,216
|
$250,608
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
|
5U54CA163060-05
|
$1,446,550
|
$86,793
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Inflammation and Colorectal Neoplasia
|
2R01CA137178-06
|
$807,379
|
$807,379
|
CHAN, ANDREW
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Chemoprotective effects of EPA and DHA on colonic adult stem cells
|
5R01CA129444-08
|
$266,015
|
$266,015
|
CHAPKIN, ROBERT
|
TEXAS A&M AGRILIFE RESEARCH
|
Total relevant funding to Chemoprevention for this search: $109,956,921
|